论文信息 - Dupilumab treatment for Allergic Bronchopulmonary Aspergillosis: A case series. - 字舞流文

Dupilumab treatment for Allergic Bronchopulmonary Aspergillosis: A case series.

F. Eun-Hyung Lee | M. Kuruvilla | R. Ramonell | C. Swenson

[1] C. Bachert,et al. Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis , 2019, Allergy.

[2] M. Garg,et al. A Randomized Trial of Itraconazole vs Prednisolone in Acute‐Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma , 2018, Chest.

[3] Matthew C. Altman,et al. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis. , 2017, The journal of allergy and clinical immunology. In practice.

[4] B. Rubin,et al. Inhibition of IL‐13‐induced periostin in airway epithelium attenuates cellular protein expression of MUC5AC , 2017, Respirology.

[5] Wei-jun Cao,et al. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. , 2017, Respiratory medicine.

[6] A. Shah,et al. Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity , 2016, Allergy, asthma & immunology research.

[7] R. Slavin,et al. Allergic bronchopulmonary aspergillosis. , 2014, The journal of allergy and clinical immunology. In practice.

[8] K. Fukunaga,et al. Induction of Mucin and MUC5AC Expression by the Protease Activity of Aspergillus fumigatus in Airway Epithelial Cells , 2011, The Journal of Immunology.

[9] V. Kurup,et al. Increased sensitivity to IL‐4 in cystic fibrosis patients with allergic bronchopulmonary aspergillosis , 2004 .